Reuters logo
BRIEF-Macrogenics says confirmed that it expects to complete enrollment of the pivotal sophia study by late 2018
December 13, 2016 / 9:59 PM / 9 months ago

BRIEF-Macrogenics says confirmed that it expects to complete enrollment of the pivotal sophia study by late 2018

Dec 13 (Reuters) - Macrogenics Inc :

* Says confirmed that it expects to complete enrollment of the pivotal sophia study by late 2018

* Says plans to submit an investigational new drug (ind) application for mgc018 in 2018 Source text - bit.ly/2hjnT6b Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below